Curis, Inc.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, whic…
Biotechnology
US, Lexington [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Curis, Inc. has no acquisition track records yet.
M&A Deals · History
Curis, Inc. has no acquisition track records yet.